Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
United European Gastroenterology Journal|December 15, 2017
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by <i>Clostridium difficile</i> toxin A in Caco-2 cellsStefano Gigli, Luisa Seguella, Marcella Pesce, et al.
The Journal of Clinical Investigation|February 15, 2022
LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstructionMohammad M Ahmadzai, Jonathon L McClain, Christine Dharshika, et al.
International Journal of Molecular Sciences|July 4, 2019
S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 CellsLuisa Seguella, Riccardo Capuano, Mirella Pesce, et al.
Metabolites|May 28, 2022
Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent ActionAlessandro Del Re, Irene Palenca, Luisa Seguella, et al.
Phytotherapy Research : PTR|October 13, 2021
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell lineChiara Corpetti, Alessandro Del Re, Luisa Seguella, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 16, 2020
Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional DyspepsiaGiovanni Sarnelli, Marcella Pesce, Luisa Seguella, et al.
International Journal of Molecular Sciences|May 28, 2022
Next-Generation Probiotics for Inflammatory Bowel DiseaseMarcella Pesce, Luisa Seguella, Alessandro Del Re, et al.
Frontiers in Pharmacology|June 1, 2016
Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB PathwayGiuseppe Esposito, Nicola Nobile, Stefano Gigli, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 24, 2025
Hyperactive Enteric Glia Contribute to Persistent Dysmotility Following Inflammation by Driving Aberrant Excitatory Responses in NeuronsLuisa Seguella, Beatriz Thomasi, Silvia Basili Franzin, et al.
Frontiers in Pharmacology|July 8, 2024
Gut-directed therapy in Parkinson's diseaseLaura Benvenuti, Clelia Di Salvo, Gabriele Bellini, et al.
Pageof 5